Search research articles
Contact Us
Filters
Showing results (481-490 of 492) with videos related to
Page
of 50
Sort By:
Cancer Research
|
July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
Chelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Molecular Cancer Therapeutics
|
March 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young
Ashleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Molecular Cancer Therapeutics
|
April 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
Ashleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Nature Genetics
|
October 31, 2018
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome
Tenzin Gayden, Fernando E Sepulveda, Dong-Anh Khuong-Quang, et al.
Nature Genetics
|
November 16, 2018
Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome
Tenzin Gayden, Fernando E Sepulveda, Dong-Anh Khuong-Quang, et al.
Genome Medicine
|
April 4, 2023
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Chelsea Mayoh, Andrew J Gifford, Rachael Terry, et al.
Nature Medicine
|
June 6, 2024
Precision-guided treatment in high-risk pediatric cancers
Loretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2026
Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancer
Noemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh, et al.
EMBO Molecular Medicine
|
December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer
Loretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Cancer Cell
|
March 31, 2023
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
Claire Xin Sun, Paul Daniel, Gabrielle Bradshaw, et al.
Page
of 50
Search research articles
Search
Showing results (481-490 of 492) with videos related to
Sort By:
Page
of 50
Cancer Research
|
July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
Chelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Molecular Cancer Therapeutics
|
March 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young
Ashleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Molecular Cancer Therapeutics
|
April 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young
Ashleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Nature Genetics
|
October 31, 2018
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome
Tenzin Gayden, Fernando E Sepulveda, Dong-Anh Khuong-Quang, et al.
Nature Genetics
|
November 16, 2018
Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome
Tenzin Gayden, Fernando E Sepulveda, Dong-Anh Khuong-Quang, et al.
Genome Medicine
|
April 4, 2023
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Chelsea Mayoh, Andrew J Gifford, Rachael Terry, et al.
Nature Medicine
|
June 6, 2024
Precision-guided treatment in high-risk pediatric cancers
Loretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2026
Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancer
Noemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh, et al.
EMBO Molecular Medicine
|
December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer
Loretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Cancer Cell
|
March 31, 2023
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
Claire Xin Sun, Paul Daniel, Gabrielle Bradshaw, et al.
Page
of 50